| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |